Just looking through the microcap conference presentation.I find...

Just looking through the microcap conference presentation.

I find it quite interesting that breath right, CGP's rival product had $100m USD revenues in 2006, estimated $145m USD revenue in 2012. Acquired by GSK for $566m USD in 2007.

This just goes to show how big the turbine could potentially be, lets not forget that the turbine is more effective than breath right in being able to deliver increased airflow into the lungs 38% more effective to be precise.

imo the turbine looks like a product that once you use it you cant go without. Has the potential to go viral once a few big names get behind.

Just wait until they launch into the well being and snoring market next year. That will be the game changer imo.

DYOR